Snigdha Prakash reports on new documents showing that drug giant Parke Davis promoted the use of neurontin for pain treatment, even though it was not approved by the FDA for that use. Documents come from a trial underway in federal court in Boston.
Copyright 2002 NPR
NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.
Give today. A monthly donation of $5 makes a real difference.
